The MHRA is currently investigating an incident where several medicines appear to have left the legal supply chain and have then been re-introduced via Kingsley Specials Ltd. Affected intermediaries, who are not implicated in the supply chain breaches but who may have supplied dispensing practices, include:

•  Smartway Pharmaceuticals Limited
•  Drugsrus Limited
• Optimal Pharma Limited

Affected items include: Eliquis, Flutiform, Seretide Evohaler, Symbicort Turbohaler and Tysabri. View the full list.

To identify affected product, dispensing practices without FMD equipment should consider using the unique serial number (SN) and/or product code (PC)/Global Trade Item Number (GTIN) information available on the outer packaging of the product.  Dispensaries should quarantine all remaining stock and hold it pending further instruction from the relevant supplier.

• GL Pharma is recalling one batch of Oxylan 40mg prolonged-release tablets (oxycodone hydrochloride) due to out of specification results for dissolution during routine stability testing.

The affected  batch is as follows:

Dispensary teams are asked to quarantine all stock for return to your supplier.